Transgender Estradiol Affirming Therapy (TREAT)
Transgenderism

About this trial
This is an interventional treatment trial for Transgenderism focused on measuring Transgender female, Gender affirming hormone therapy, Estrogen therapy
Eligibility Criteria
Inclusion Criteria:
- Female transgender patients between the ages of 18 to 30 years of age who are seen at the Washington University Transgender Center. Patients must have met the eligibility and readiness criteria for gender-affirming hormone therapy.
Exclusion Criteria:
- GnRH agonist for the last 12 months
- History of liver disease
- Dyslipidemia requiring treatment
- Cigarette smoking
- Body mass index >30 kg/m2
Sites / Locations
- Washington University Transgender CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Active Comparator
Active Comparator
Transdermal estradiol plus spironolactone
Daily sublingual estradiol plus spironolactone
Twice daily sublingual estradiol plus spironolactone
Starting dose will be 100 mcg/24hrs Plan to increase by 100 mcg/24hrs every month to a max dose of 400 mcg/24hrs Goal is to achieve a serum estradiol level between 100-200 pg/mL and to suppress testosterone to cisgender female levels All patients will also receive spironolactone. Spironolactone will be started at 50 mg daily and will increase to standard dose.
Starting dose will be 2 mg daily Plan to increase every month by 2 mg daily Goal is to achieve serum estradiol level between 100-200 pg/mL mL and to suppress testosterone to cisgender female levels. All patients will also receive spironolactone. Spironolactone will be started at 50 mg daily and will increase to standard dose. Spironolactone will be started at 50 mg daily and will increase to standard dose.
Starting dose will be 1 mg twice daily Plan to increase every month by 2 mg daily divided BID Goal is to achieve serum estradiol level between 100-200 pg/mL mL and to suppress testosterone to cisgender female levels All patients will also receive spironolactone. Spironolactone will be started at 50 mg daily and will increase to standard dose. Spironolactone will be started at 50 mg daily and will increase to standard dose.